Ignite Creation Date:
2025-12-24 @ 11:29 PM
Ignite Modification Date:
2026-04-19 @ 8:48 PM
Study NCT ID:
NCT01249456
Status:
COMPLETED
Last Update Posted:
2015-06-25
First Post:
2010-11-25
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Safety and Efficacy Study of Femara(Letrozole) as an Extended Adjuvant Treatment in Breast Cancer Patients
Sponsor:
Novartis Pharmaceuticals
Organization:
Organization Data
Organization:
Class:
INDUSTRY
Study ID:
CFEM345DKR04
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None